Literature DB >> 7305709

Are most iris "melanomas' really nevi? A clinicopathologic study of 189 lesions.

F A Jakobiec, G Silbert.   

Abstract

A retrospective clinicopathologic study of 189 iris and iris and ciliary body lesions originally diagnosed as melanomas led to a nine-part histopathologic classification. Eighty-seven percent of lesions were reassigned to six benign categories and 13% were assigned to three malignant ones (spindle-B and epithelioid cell melanomas). There were no tumor deaths. The benign lesions were so classified if the constituent cells displayed bland cytologic characteristics, even though they might have produced a surface plaque or growth onto the trabecular meshwork and peripheral cornea. No clinical features were found to distinguish the benign from malignant tumors, including diffuse spread and the presence of glaucoma. The six recurrent tumors were equally divided between benign and malignant lesions. Thirty-six of 42 patients with incompletely excised lesions did not show further clinical problems on follow-up, establishing the inherently benign nature of most of the tumors.

Entities:  

Mesh:

Year:  1981        PMID: 7305709     DOI: 10.1001/archopht.1981.03930020993002

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  19 in total

Review 1.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

Review 2.  Prognosis in ocular melanoma.

Authors:  J Hungerford
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

3.  Iris pigmentation and pigmented lesions: an ultrastructural study.

Authors:  R C Eagle
Journal:  Trans Am Ophthalmol Soc       Date:  1988

4.  Irradiating iris tumours.

Authors:  I Rennie
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

5.  High frequency ultrasound.

Authors:  H R Atta
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

6.  Factors associated with elevated intraocular pressure in eyes with iris melanoma.

Authors:  C L Shields; M A Materin; J A Shields; E Gershenbaum; A D Singh; A Smith
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

7.  Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma.

Authors:  H E Grossniklaus
Journal:  Trans Am Ophthalmol Soc       Date:  1998

8.  An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.

Authors:  U Fuchs; T Kivelä; P Summanen; I Immonen; A Tarkkanen
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

9.  Malignant transformation of an iris melanocytoma. A case report.

Authors:  A P Cialdini; J A Sahel; A E Jalkh; J J Weiter; K Zakka; D M Albert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

10.  Iris nevi and melanomas: a clinical follow-up study.

Authors:  F van Klink; R J de Keizer; M J Jager; H M Kakebeeke-Kemme
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.